A combination of bortezomib and rituximab yields a dramatic response in a woman with highly refractory immune thrombocytopenic purpura: a case report

Peer Review reports

Original Submission
13 Sep 2013	Submitted	Original manuscript
18 Sep 2013	Author responded	Author comments - Namita Vinayek
Resubmission - Version 2
18 Sep 2013	Submitted	Manuscript version 2
1 Oct 2013	Reviewed	Reviewer Report - Simon Panzer
21 Oct 2013	Reviewed	Reviewer Report - bertrand Godeau
22 Nov 2013	Author responded	Author comments - Namita Vinayek
Resubmission - Version 3
22 Nov 2013	Submitted	Manuscript version 3
26 Nov 2013	Author responded	Author comments - Namita Vinayek
Resubmission - Version 4
26 Nov 2013	Submitted	Manuscript version 4
Publishing
2 Dec 2013	Editorially accepted
15 Jan 2014	Article published	10.1186/1752-1947-8-19

Back to article page